title: Monoclonal antibodies in adult acute lymphoblastic leukemia.
abstract: Monoclonal antibodies targeting surface markers in acute lymphocytic leukemia (CD19, CD20 and CD22) are showing promising results and are reviewed.
authors.affiliation: Leukemia Department, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 428, Houston, TX 77030, USA. hkantarj@mdanderson.org
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D000328:Adult; D018033:Antibodies, Bispecific / Q000276:immunology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D000922:Immunotoxins / Q000276:immunology / Q000627:therapeutic use; D000080045:Inotuzumab Ozogamicin; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab
chemical_list: D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000922:Immunotoxins; D000069283:Rituximab; C510808:blinatumomab; D000080045:Inotuzumab Ozogamicin